Противовирусный препарат Кагоцел и новый коронавирус SARS-CoV-2 (COVID-19)

Another Russian Pharma Award for Kagocel

On November 23, the results of the practicing doctors’ voting for the best in the pharma market in 2017 were made known. In the framework of the annual Russian Pharma Awards, experts identified the best of the best in more than 20 different categories. The antiviral drug Kagocel received another award in the nomination Most Often Prescribed Drug For The Treatment Of SARS And Influenza. 

Kagocel becomes winner of this award for the fourth year in a row, confirming its position as the leader. Half a million doctors who are registered in the Doctor at Work professional network vote for best of the best in various fields of medicine. 

It is the practitioners who can make a professional choice of the most effective, convenient to use, and safe products, which makes the results of the Russian Pharma Awards a veritable indicator of the quality of winners selected by experts. 

← Back to the list